XML 64 R58.htm IDEA: XBRL DOCUMENT v3.25.2
Balance Sheet Components - Schedule of Other Accrued Liabilities (Details) - USD ($)
$ in Thousands
Jun. 30, 2025
Dec. 31, 2024
Balance Sheet Related Disclosures [Abstract]    
Accrued contract manufacturing expenses $ 560 $ 1,071
Accrued clinical and research expenses 275 611
Accrued professional services $ 5,279 $ 8,682
Operating Lease, Liability, Current, Statement of Financial Position [Extensible Enumeration] Total other accrued liabilities Total other accrued liabilities
Current portion of lease liabilities $ 983 $ 1,572
Royalty obligation payable 3,112 2,951
Current portion of deferred royalty obligations 7,398 6,438
Accrued license fees and royalties 1,990 1,727
Other [1] 18,388 6,947
Total other accrued liabilities $ 37,985 $ 29,999
[1] Amount as of June 30, 2025 and December 31, 2024 includes $16.1 million and $5.3 million advance payments received from our partner for inventory supply as discussed in Note 4, “License and Collaboration Arrangements”.